AI drug discovery company

Waypoint Bio

Data as of Oct 17, 2026.

Company facts

Founded

2021

ReportedSource for founded (opens in new tab)
Headquarters

United States (New York)

ConfirmedSource for headquarters (opens in new tab)

Latest funding round

Round: Series A
Date: May 27, 2026
Amount: $20M
Lead investor: Amplify Partners

ConfirmedSource for the latest round (opens in new tab)

Recent news

Jun 1, 2026

Raised $20M Series A, AI-native spatial biology

ConfirmedSource (opens in new tab)
Oct 29, 2025

Names Patrick Kaifosh, co-founder of CTRL-Labs, as CTO

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.